|
Search
Collections
Benchmarks
Upload document
Product
IXAZOMIB
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 indication
Indication
Systemic Light Chain Amyloidosis
Clinical trial
A Phase 3, Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of Dexamethasone Plus MLN9708 or Physicians Choice of Treatment Administered to Patients With Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Status: Terminated
, Estimated PCD: 2022-07-11